Arvinas, Inc. (NASDAQ:ARVN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 11, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.63, ...
Labroots2d
Molecule May Help Retain Muscle Mass When Losing Fat
Muscle mass plays a crucial role in overall health, strength, and metabolic function, making its regulation essential for maintaining quality of life. A re | Cell And Molecular Biology ...
Arvinas Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Announced that topline data from the monotherapy Phase 3 VERITAC-2 trial isanticipated in 1Q25 –– Presented Phase 1b data from the TACTIVE-U ...
Arvinas announces anticipated upcoming milestones
As part of Arvinas global collaboration with Pfizer, the companies plan to: Announce topline data for the VERITAC-2 Phase 3 monotherapy cli ...
News Medical6d
Immune gene expression changes in myocardial infarction revealed through bioinformatics
Announcing a new article publication for Cardiovascular Innovations and Applications journal. This study was aimed at exploring immune-related genes and their expression changes in myocardial ...